Overview
Bionorica Polska focuses on medicines and a medicinal plant catalogue. The company also provides information about its activities.
Financials
Revenue history (in m)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2008-04-29. Active
71 1600 1462 1881 4047 5000 0001- 33 1600 1462 1881 4047 5000 0006
- 17 1600 1462 1881 4047 5000 0003
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Bionorica Polska currently holds no active trademarks with the Polish Patent Office. 4 marks have expired or were not registered. The first mark was filed in 2013.
| Mark | Protected until | |
|---|---|---|
| Imulan(word) | – | |
| Bronchilan(word) | – | |
| Rinulan(word) | – | |
| Canephrolan(word) | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
If only one member of the management board has been appointed, they represent the company independently. In the case of a multi-member management board, the company is represented by two members of the management board acting jointly or by one member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bionorica Se | 500 | $135,062.13 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrala Farmaceutyczna CefarmS.A. | $457,052,669.59 | cefarm.com.pl | ||
| ITPS.A. | $55,285,362.18 | itpsa.pl | ||
| Ivoclar-Vivadent Polskasp. z o.o. | $17,154,419.26 | ivoclar.com | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| IMC Impomed CentrumS.A. | $4,447,564.10 | impomed.pl | ||
| Gtm-Mobil M-T T.Walisiewiczsp. k. | $3,438,533.82 | gtmmobil.com.pl | ||
| Reynolds Medicalsp. z o.o. | $3,313,657.78 | reymed.pl | ||
| Petronafsp. z o.o. | $2,499,010.09 | petronaf.com | ||
| CryoprofilS.A. | $1,470,469.25 | cryoprofil.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com |
Change history
| Date | Event | |
|---|---|---|
| 2021-01-22 | Address change (Leszno 14, 01-192, Warszawa → Ul. Hrubieszowska 6b, 01-209, Warszawa) | |
| 2011-06-11 | Address change (Pandy 8, 02-202, Warszawa → Leszno 14, 01-192, Warszawa) | |
| 2008-07-07 | Address change (Al. Szucha 13/15, 00-580, Warszawa → Pandy 8, 02-202, Warszawa) | |
| 2008-04-14 | Entered in the register |
FAQ
Last updated: 2026-10-07